1. Home
  2. UEC vs KRYS Comparison

UEC vs KRYS Comparison

Compare UEC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uranium Energy Corp.

UEC

Uranium Energy Corp.

HOLD

Current Price

$11.88

Market Cap

6.5B

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$212.75

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UEC
KRYS
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.3B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
UEC
KRYS
Price
$11.88
$212.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$15.80
$214.22
AVG Volume (30 Days)
9.3M
306.6K
Earning Date
12-05-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
275.72
EPS
N/A
6.66
Revenue
$66,837,000.00
$373,164,000.00
Revenue This Year
$4.84
$34.33
Revenue Next Year
$103.03
$48.04
P/E Ratio
N/A
$32.32
Revenue Growth
29737.94
54.51
52 Week Low
$3.85
$122.80
52 Week High
$17.80
$221.84

Technical Indicators

Market Signals
Indicator
UEC
KRYS
Relative Strength Index (RSI) 45.30 68.40
Support Level $10.39 $213.24
Resistance Level $12.47 $221.84
Average True Range (ATR) 0.83 6.84
MACD 0.06 0.19
Stochastic Oscillator 70.75 75.57

Price Performance

Historical Comparison
UEC
KRYS

About UEC Uranium Energy Corp.

Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: